Cargando…
Erratum to “Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients”
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585674/ https://www.ncbi.nlm.nih.gov/pubmed/28913368 http://dx.doi.org/10.1155/2017/7869412 |
_version_ | 1783261680595107840 |
---|---|
author | Lee, Sang Jin Park, Won Park, Sung Hwan Shim, Seung-Cheol Baek, Han Joo Yoo, Dae-Hyun Kim, Hyun Ah Lee, Soo Kon Lee, Yun Jong Park, Young Eun Cha, Hoon-Suk Park, Jin Kyun Lee, Eun Young Lee, Eun Bong Song, Yeong Wook |
author_facet | Lee, Sang Jin Park, Won Park, Sung Hwan Shim, Seung-Cheol Baek, Han Joo Yoo, Dae-Hyun Kim, Hyun Ah Lee, Soo Kon Lee, Yun Jong Park, Young Eun Cha, Hoon-Suk Park, Jin Kyun Lee, Eun Young Lee, Eun Bong Song, Yeong Wook |
author_sort | Lee, Sang Jin |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5585674 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-55856742017-09-14 Erratum to “Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients” Lee, Sang Jin Park, Won Park, Sung Hwan Shim, Seung-Cheol Baek, Han Joo Yoo, Dae-Hyun Kim, Hyun Ah Lee, Soo Kon Lee, Yun Jong Park, Young Eun Cha, Hoon-Suk Park, Jin Kyun Lee, Eun Young Lee, Eun Bong Song, Yeong Wook J Immunol Res Erratum Hindawi 2017 2017-08-20 /pmc/articles/PMC5585674/ /pubmed/28913368 http://dx.doi.org/10.1155/2017/7869412 Text en Copyright © 2017 Sang Jin Lee et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Erratum Lee, Sang Jin Park, Won Park, Sung Hwan Shim, Seung-Cheol Baek, Han Joo Yoo, Dae-Hyun Kim, Hyun Ah Lee, Soo Kon Lee, Yun Jong Park, Young Eun Cha, Hoon-Suk Park, Jin Kyun Lee, Eun Young Lee, Eun Bong Song, Yeong Wook Erratum to “Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients” |
title | Erratum to “Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients” |
title_full | Erratum to “Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients” |
title_fullStr | Erratum to “Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients” |
title_full_unstemmed | Erratum to “Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients” |
title_short | Erratum to “Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients” |
title_sort | erratum to “low baseline interleukin-17a levels are associated with better treatment response at 12 weeks to tocilizumab therapy in rheumatoid arthritis patients” |
topic | Erratum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585674/ https://www.ncbi.nlm.nih.gov/pubmed/28913368 http://dx.doi.org/10.1155/2017/7869412 |
work_keys_str_mv | AT leesangjin erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients AT parkwon erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients AT parksunghwan erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients AT shimseungcheol erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients AT baekhanjoo erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients AT yoodaehyun erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients AT kimhyunah erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients AT leesookon erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients AT leeyunjong erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients AT parkyoungeun erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients AT chahoonsuk erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients AT parkjinkyun erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients AT leeeunyoung erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients AT leeeunbong erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients AT songyeongwook erratumtolowbaselineinterleukin17alevelsareassociatedwithbettertreatmentresponseat12weekstotocilizumabtherapyinrheumatoidarthritispatients |